Importantly, DRP1 genetic loss in PDAC impaired tumor growth and showed analogous features in terms of mitochondrial dysfunction [17], validating our experimental approach using the pharmacological inhibitor mDivi-1. This evidence concerns the gene DNM1L and neoplasm.